News from access pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 22, 2014, 08:30 ET

Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), has signed an exclusive, global license agreement with Plasma Technologies LLC ("PlasmaTech") for the...

Aug 14, 2014, 09:16 ET

Access Pharmaceuticals Awarded Japan Patent For MuGard And ProctiGard

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, has received notification from the Japan Patent Office that a...

Aug 07, 2014, 08:00 ET

Access Pharmaceuticals Announces European License Agreement With Norgine

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, today announced that it had entered into an exclusive...

Jul 30, 2014, 08:30 ET

Access Pharmaceuticals Featured On OncLive.com

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced that its novel product for oral...

Jul 22, 2014, 08:30 ET

Access Pharmaceuticals Receives 510(K) FDA Marketing Clearance For ProctiGard™

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced today that it has received...

Jul 08, 2014, 10:56 ET

Access Pharmaceuticals Awarded Hong Kong Patent For MuGard

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, has received notification from the Hong Kong Patent Office that...

May 01, 2014, 08:30 ET

Access Pharmaceuticals MuGard Selected For Cover Article In The Print Edition Of The Journal Cancer

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced that the data from its multi-institutional post-approval trial of MuGard® that was...

Apr 15, 2014, 08:30 ET

Positive Results Of MuGard Study In Erosive Oral Lichen Planus Presented At International Oral Medicine Meeting

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biotechnology company, announced today that positive results from a study conducted at...

Apr 08, 2014, 08:30 ET

Access Pharmaceuticals Provides Update On Development Of LexaGard, A Proprietary Formulation Of Amlexanox

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called...

Apr 01, 2014, 08:16 ET

Access Pharmaceuticals Provides Strategic Update On Mucoadhesive Polymer Hydrogel Technology

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided investors with a strategic update on its programs and plans for its proprietary...

Mar 26, 2014, 08:14 ET

Access Pharmaceuticals Cobraxane™ Offers Enhanced Tumor Growth Inhibition In Tumor Models

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biotechnology company, announced today that it is leveraging its proprietary...

Mar 21, 2014, 08:30 ET

Access Pharmaceuticals Advances Development of ProctiGard™ for Radiation Proctitis

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced that it has advanced development of a new proprietary product, called ProctiGard™, for...

Mar 11, 2014, 08:52 ET

Access Pharmaceuticals Announces MuGard License Agreement With Hanmi Pharmaceutical In Korea

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) today announced that it had entered into an exclusive license agreement with HANMI PHARMACEUTICAL...

Feb 18, 2014, 08:30 ET

Access Pharmaceuticals Announces Publication Of MuGard Clinical Data In Cancer Journal

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced the online early publication of the final results of its post-approval marketing study of...

Sep 24, 2013, 10:42 ET

Access Pharmaceuticals Announces MuGard Poster Presentation At ASTRO Conference

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, announced a poster presentation at the American Society for...

Sep 12, 2013, 08:30 ET

Access Pharmaceuticals Awarded Second European Patent for MuGard

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, has received notification from the European Patent Office...

Jul 26, 2013, 11:00 ET

Access Pharmaceuticals To Host Investor Call On Wednesday, July 31, 2013

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, will host an investor call to update investors on recent...

Jun 27, 2013, 08:00 ET

Access Pharmaceuticals Announces Positive Top-Line Data From MuGard™ Phase IV Clinical Trial In Oral Mucositis Patients Presented At MASCC/ISOO 2013 Symposium

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, announced that Dr. Ron R. Allison of Carolina Radiation...

Jun 10, 2013, 08:00 ET

Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals For MuGard

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, today announced that it had entered into an exclusive...

May 16, 2013, 08:30 ET

Access Pharmaceuticals Reports First Quarter Results

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, released its first quarter ended March 31, 2013 financial...